Ciliary Function in Adults with Bronchiectasis
Part of Lungs & breathing clinical trials.
This study looks for signs of ciliary dyskinesia (a condition affecting tiny hair-like structures in the lungs) in adults who have bronchiectasis (damaged airways). Understanding this connection may help doctors better treat and manage your lung disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have bronchiectasis confirmed by a CT scan of your chest
- You do not have cystic fibrosis
- You do not have a previous diagnosis of primary ciliary dyskinesia
- You are able to participate in study testing procedures
- You are willing to sign a consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks whether special nose tests help doctors choose the best treatments for children with long-term breathing and airway symptoms. It may help your child get more targeted care based on the test results.
This study tests whether a breathing test called nasal nitric oxide can help improve care for people with primary ciliary dyskinesia (PCD) or related lung/sinus problems. The goal is to see if the test can better guide diagnosis and treatment planning.
This trial is studying how a mask that helps you breathe (non-invasive ventilation) affects people with bronchiectasis (a condition where airways in the lungs are stretched and scarred). It may help doctors understand if this treatment improves quality of life or slows the disease.
This study helps doctors identify different types of bronchiectasis (a lung disease where airways are permanently widened and damaged) to better understand how the disease develops and progresses. By following patients over time and collecting medical information, researchers hope to create a system that predicts which patients will worsen and need different treatments.
This study is looking at people with bronchiectasis (a lung condition that causes coughing and mucus) to understand how different types of inflammation in sputum (mucus from the lungs) affect their health over time. It may help find better treatments for those with frequent lung infections.
This trial tests an inhaled medication called CSL787 to see if it can help people with non-cystic fibrosis bronchiectasis (a lung condition that causes frequent infections and breathing problems). The study looks at different doses and checks how well the drug works and if it is safe.
Hear when a new Idiopathic Bronchiectasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.